CareDx
CDNA
#5985
Rank
C$1.36 B
Marketcap
C$25.60
Share price
-4.53%
Change (1 day)
-26.08%
Change (1 year)

P/E ratio for CareDx (CDNA)

P/E ratio as of December 2025 (TTM): 14.3

According to CareDx's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 14.3192. At the end of 2024 the company had a P/E ratio of 21.2.

P/E ratio history for CareDx from 2014 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202421.2
2022-7.92-89.72%
2021-77.1-55.31%
2020-172315.86%
2019-41.5119.45%
2018-18.9469.13%
2017-3.32204.74%
2016-1.09-80.42%
2015-5.57-106.83%
201481.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
T2 Biosystems
TTOO
-0.0015-100.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Agios Pharmaceuticals
AGIO
2.39-83.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Invitae
NVTA
-0.0060-100.04%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.